Table 2.
Coverage of mass drug administration regimens for scabies and trachoma
| Number receiving treatment (n=26 188) | ||
|---|---|---|
| Scabies regimen first dose | 25 819 (98·6%) | |
| Oral ivermectin | 21 444 (83·1%) | |
| Topical permethrin | 4375 (16·9%) | |
| Scabies regimen second dose | 21 931 (83·7%) | |
| Oral ivermectin | 18 215 (83·1%) | |
| Topical permethrin | 3716 (16·9%) | |
| Trachoma regimen | 25 717 (98·2%) | |
| Oral azithromycin | 25 278 (98·3%) | |
| Topical tetracycline | 439 (1·7%) | |
| Combination scabies and trachoma regimen (first dose for scabies) | 25 488 (97·3%) | |
| Coadministration of ivermectin (first dose) and azithromycin | 21 181 (83·1%) | |
| Combination scabies and trachoma regimen (both doses for scabies) | 21 817 (85·6%) | |